NMDAR PAMs work by either increasing maximal current (type I effect) or decreasing agonist EC50 (type II effect), or both.
Several chemically distinct classes of NMDAR PAMs with distinct binding sites and modes of action are described.
Potential consequences of different types of PAM effects on brain function (desirable and undesirable) are considered.